(Q38764874)

6 September 2017

title

Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents (English)

1 reference

6 September 2017

0 references

Edward H Clayton

1

1 reference

6 September 2017

Tanya L Hanstock

series ordinal

2

1 reference

6 September 2017

Manohar L Garg

series ordinal

3

1 reference

6 September 2017

Philip L Hazell

series ordinal

4

1 reference

6 September 2017

language of work or name

1 reference

1 April 2007

1 reference

6 September 2017

published in

Acta Neuropsychiatrica

1 reference

6 September 2017

volume

19

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

92-103

1 reference

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Clinical characteristics and serum essential fatty acid levels in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

A lack of essential fatty acids as a possible cause of hyperactivity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The emerging role of omega-3 fatty acids in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Lithium decreases turnover of arachidonate in several brain phospholipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Omega-3 fatty acids in the treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Omega-3 fatty acids and bipolar disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Fish oils and bipolar disorder: a promising but untested treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Protein kinase inhibition by omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Plasma fatty acid levels in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The role of long-chain polyunsaturated fatty acids in infant cognitive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Infant cerebral cortex phospholipid fatty-acid composition and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Lipids of nervous tissue: composition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Cultured skin fibroblasts as a cell model for investigating schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Fatty acid levels in the brains of schizophrenics and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Cross-national comparisons of seafood consumption and rates of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Fat consumption and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Cross-national epidemiology of major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Statistical analysis of repeated measures data using SAS procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Polyunsaturated fatty acid deficit in patients with bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Advances in the neurobiology of pediatric bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

Omega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2007.00189.X

10.1111/J.1601-5215.2007.00189.X

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference